

Author: Toffoli G.
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.43, Iss.7, 2004-01, pp. : 441-466
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Pharmacokinetic Optimisation of the Treatment of Neurocysticercosis
Clinical Pharmacokinetics, Vol. 34, Iss. 6, 1998-06 ,pp. :


Pharmacokinetic Optimisation in the Treatment of Parkinson's Disease: An Update
By Nyholm Dag
Clinical Pharmacokinetics, Vol. 45, Iss. 2, 2006-01 ,pp. :



